Asia-Pacific Cardiac AI Monitoring and Diagnostics Market Report - Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
13 Feb 2024
DUBLIN, Feb. 12, 2024 /PRNewswire/ -- The "Asia-Pacific Cardiac AI Monitoring and Diagnostics Market: Analysis and Forecast, 2023-2032" report has been added to
ResearchAndMarkets.com's offering.
The Asia-Pacific cardiac AI monitoring and diagnostics market was valued at $200.4 million in 2023 and is anticipated to reach $2.15 billion by 2032, witnessing a CAGR of 30.20% during the forecast period 2023-2032. Growth in the cardiac AI monitoring and diagnostics market is driven by widespread cardiovascular diseases, government support for AI in healthcare, increasing cardiology-focused AI research, more regulatory approvals for AI cardiac devices, and advances in AI cardiac diagnostics technology.
The Asia-Pacific (APAC) market for cardiac AI monitoring and diagnostics is witnessing significant growth, driven by several key factors. The region faces a high burden of cardiovascular diseases, fueled by aging populations and increasing prevalence of lifestyle-related risk factors like diabetes and hypertension. This has heightened the demand for advanced diagnostic and monitoring tools. Governments across APAC are increasingly recognizing the potential of AI in healthcare, leading to supportive policies and investments in AI technology.
Additionally, the region is seeing a surge in healthcare technology research, including AI applications in cardiology, making advanced diagnostics more accessible and efficient. Furthermore, the increasing number of regulatory approvals for AI-based cardiac diagnostic devices reflects a growing trust in their effectiveness and safety. Technological advancements in AI are enhancing the precision and accuracy of cardiac diagnostics, catering to the region's diverse and expanding healthcare needs.
Market Segmentation:
Segmentation by Product
Software
Hardware
Segmentation by Type
Imaging
ECG-Based
Others
Cardiac Monitoring
Segmentation by Application
Cardiac Arrhythmias
Others
Segmentation by End User
Hospitals
Diagnostic Centers
Other End Users
Segmentation by Country
China
Japan
India
Australia
South Korea
Rest-of-Asia-Pacific
Product/Innovation Strategy: The APAC cardiac AI monitoring and diagnostics market has been extensively segmented based on various categories, such as products, types, applications, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Key Topics Covered:
Executive Summary
1 Market
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion Criteria
1.1.3 Exclusion Criteria
1.1.4 Overview
2 Industry Outlook
2.1 Key Trends
2.1.1 Rising Number of Startups in the Market
2.1.2 Increased Awareness Regarding Preventative Measures and Personalized Treatment
2.1.3 Growing Demand for Wearable Sensors for Cardiac Monitoring Leading to Increased Adoption of AI-Enabled Solutions for Home-Based Care
2.2 Opportunity Assessment
2.3 Regulatory Framework
2.4 Patent Analysis
2.5 Business Models
2.6 Case Studies
2.6.1 Case Study 1: Ultromics Limited
2.6.1.1 The EchoGo System
2.6.1.1.1 Developement
2.6.1.1.2 Use Case and Reliability
2.6.1.2 A Success Story
2.6.1.3 Partners and Recognitions
2.6.2 Case Study 2: CorVista Health, Inc.
2.6.2.1 The CorVista System
2.6.2.2 A Success Story
2.7 Ongoing Clinical Trials
2.8 Funding Scenario
2.9 End User Perception
2.1 Entry Barriers for New Entrants
3 Impact of COVID-19
4 Regions
4.1 Asia-Pacific Cardiac AI Monitoring and Diagnostics Market
4.1.1 Key Findings and Opportunity Assessment
4.1.2 Digital Adoption
4.1.3 Market Dynamics
4.1.3.1 Impact Analysis
4.1.4 Market Sizing and Forecast
5 Markets - Competitive Benchmarking & Company Profiles
5.1 Cardiac AI Monitoring and Diagnostics Active Players Ecosystem
5.2 Key Strategies and Developments
5.2.1 Regulatory and Legal Activities
5.3 Company Profiles
5.3.1 Canon Inc.
5.3.1.1 Company Overview
5.3.1.2 Role of Canon Inc. in the Cardiac AI Monitoring and Diagnostics Market
5.3.1.3 Financials
5.3.1.4 Analyst Perception
For more information about this report visit https://www.researchandmarkets.com/r/jlpetd
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo - https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.